Alabama National Association of Hispanic Nurses

The Role of Enhanced Pathogen Detection in the Management of Septic Pneumonia Patients

Webinar/Online

Tuesday, March 30, 2021 at 2:00pm ET - 3:00pm ET

Info

Topic

The clinical use of multiplex PCR platforms dramatically increases the frequency of detection of potential viral and bacterial pathogens, while the companion use of biomarkers to measure serum procalcitonin levels helps to determine whether the detected potential pathogens are colonizing or invading. This is of critical importance to antibiotic stewardship activities. In this session, presented by Sepsis Alliance Institute and sponsored by BioMérieux, attendees will learn about enhanced detection of potential viral and bacterial pathogens in septic patients with community-acquired pneumonia. Attendees will also learn to identify the important variables influencing serum procalcitonin levels and how to use serum procalcitonin levels to help determine the significance of detected viral and/or bacterial pathogens.

Interested In Attending This Event?

Additional Registration Information:

Topic: 

The clinical use of multiplex PCR platforms dramatically increases the frequency of detection of potential viral and bacterial pathogens, while the companion use of biomarkers to measure serum procalcitonin levels helps to determine whether the detected potential pathogens are colonizing or invading. This is of critical importance to antibiotic stewardship activities.

In this session, presented by Sepsis Alliance Institute and sponsored by BioMérieux, attendees will learn about enhanced detection of potential viral and bacterial pathogens in septic patients with community-acquired pneumonia. Attendees will also learn to identify the important variables influencing serum procalcitonin levels and how to use serum procalcitonin levels to help determine the significance of detected viral and/or bacterial pathogens.


Target Audience:
  

All healthcare providers.     

At the end of the presentation, the attendee should be able to: 

    • Restate the results of recent controlled clinical trial data that documents the sensitivity of the Biofire Filmarray multiplex PCR panel in the detection of potential viral and bacterial pathogens in septic patients with community-acquired pneumonia;
    • Identify the important variables that influence serum procalcitonin levels;
    • State how to use serum procalcitonin levels to help determine the significance of detected viral and /or bacterial pathogens.  

About the speakers:
David N. Gilbert, MD, MACPChief of Infectious Diseases, Providence Portland Medical Center; Professor of Medicine, Oregon Health Sciences University  

Dr. Gilbert did his infectious diseases fellowship training with Jay P. Sanford, MD, at the University of Texas Southwestern Medical School in Dallas, Texas. Dr. Gilbert is Chief of Infectious Diseases at Providence Portland Medical Center in Portland, Oregon. He is also Professor of Medicine at Oregon Health Sciences University. In the 1970s, he was on the editorial board of the Sanford Guide where his association extends back to its early editions. He was IDSA President in 2002. Dr. Gilbert’s interest is all facets of infectious disease with an emphasis on antimicrobials. His current project is the role of rapid molecular diagnostics in antimicrobial stewardship.

About Sepsis Alliance Institute:
Sepsis Alliance Institute offers free online sepsis education and resources for healthcare providers across the continuum of care in order to help improve sepsis diagnosis, treatment, and care. 

Every year in the United States, 1.7 million people are diagnosed with sepsis and over 270,000 people die of sepsis. Sepsis is the most expensive in-patient cost in U.S. hospitals. In-patient hospital and skilled nursing costs for sepsis care are approximately $62 billion per year.   

Through Sepsis Alliance Institute, more than 10,000 learners are currently earning over 21,000 CE credits and learning the best practices in sepsis recognition, treatment, and care. Click to find out more.